In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 6th, 2004 | 21 | Yes |
Popular Name: Bupivacaine hydrochloride Bupivacaine hydrochloride
Find On: PubMed — Wikipedia — Google
CAS Numbers: 14252-80-3 , 14252-80-3, 2180-92-9 [bu , 14252-80-3, 2180-92-9 [bupivacaine], 18010-40-7 [anhydrous] , 18010-40-7 , 2180-92-9 , 27262-45-9 , 27262-48-2 , 38396-39-3 , [14252-80-3] , [18010-40-7] , [2180-92-9] , [38396-39-3]
( inverted exclamation markA)-bupivacaine
(1)-1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
1-Butyl-2',6'-pipecoloxylidide
1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide
1-Butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide
1-Butyl-piperidine-2-carboxylic acid (2,6-dimethyl-phenyl)-amide
18010-40-7; Bupivacaine hydrochloride; Prestwick_894
2',6'-Pipecoloxylidide, 1-butyl-
2',6'-Pipecoloxylidide, 1-butyl-, hydrochloride, (+)-; Bupicaine hydrochloride (+); LS-109845
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-
2-Piperidinecarboxamide, 1-butyl-N-(2,6-dimethylphenyl)-, (+-)-
2180-92-9; Bucaine (TN); Bupivacaine (USAN/INN); D07552; Exparel (TN)
bupivacaina; bupivacaine; bupivacainum
bupivacaine hydrochloride (anhydrous)
Bupivacaine hydrochloride (Marcain)
bupivacaine hydrochloride hydrate
Bupivacaine Monohydrochloride, Monohydrate
dl-1-Butyl-2',6'-pipecoloxylidide
Marcain, Marcaine, Sensorcaine, Vivacaine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.34 | 10.3 | -35.63 | 2 | 3 | 1 | 34 | 289.443 | 5 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
mechanism | . | ZereneX Building Blocks |
ALOGPS_SOLUBILITY | 9.77e-02 g/l | DrugBank-approved |
Purity | 95% | Fluorochem |
Purity | >95% | Fluorochem |
Therapy | anesthetic (local) | SMDC Iconix |
mechanism | Blocks the generation and the conduction of nerve impulses, | IBScreen Bioactives |
PUBCHEM_PATENT_ID | EP0757555A1; EP0914441A2; EP0920522A1; EP0963202A1; US5149320; US5209724; US5226901; US5261903; US5610184; US5760077; US6046187; WO1997040165A1; WO1998006863A1; WO1998010769A1; WO1999062581A2; WO2000009145A1 | IBM Patent Data |
Patent Database Links | EP1405646; EP1559418; EP1576953; EP1586347; EP1685843; EP1702597; EP1712220; EP1762236; EP1772767; EP1813295; EP1815846; EP1829527; EP1829528; EP1834627; EP1894559; EP1902705; EP1972684; EP1990639; US2004068007; US2004254182; US2007189977; US2007189978; U | ChEBI |
biological_use | Local anaesthetic | IBScreen Bioactives |
Indications | local anesthetic | KeyOrganics Bioactives |
Target | Others | Selleck Chemicals |
mechanism | presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential | IBScreen Bioactives |
Target | Sodium Channel | Selleck Chemicals |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SCN1A-1-E | Sodium Channel Protein Type I Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5400 | 0.35 | Binding ≤ 10μM |
SCN2A-1-E | Sodium Channel Protein Type II Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5400 | 0.35 | Binding ≤ 10μM |
SCN3A-1-E | Sodium Channel Protein Type III Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5400 | 0.35 | Binding ≤ 10μM |
SCN8A-1-E | Sodium Channel Protein Type VIII Alpha Subunit (cluster #1 Of 2), Eukaryotic | Eukaryotes | 5400 | 0.35 | Binding ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
SCN1A_HUMAN | P35498 | Sodium Channel Protein Type I Alpha Subunit, Human | 5400 | 0.35 | Binding ≤ 10μM |
SCN2A_HUMAN | Q99250 | Sodium Channel Protein Type II Alpha Subunit, Human | 5400 | 0.35 | Binding ≤ 10μM |
SCN3A_HUMAN | Q9NY46 | Sodium Channel Protein Type III Alpha Subunit, Human | 5400 | 0.35 | Binding ≤ 10μM |
SCN8A_HUMAN | Q9UQD0 | Sodium Channel Protein Type VIII Alpha Subunit, Human | 5400 | 0.35 | Binding ≤ 10μM |
Description | Species |
---|---|
Interaction between L1 and Ankyrins |